HI
ARMP icon

Harbour Investments’s Armata Pharmaceuticals ARMP Stock Holding History

Harbour Investments’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21
Closed – – 2668
2021
Q3 		$0 Hold
21
– – ﹤0.01% 3714
2021
Q2 		$0 Hold
21
– – ﹤0.01% 3751
2021
Q1 		$0 Buy
+21
New +$103 ﹤0.01% 3585

Other funds holding ARMP

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Harbour Investments's ARMP Position: Q4 2021 in Review

Harbour Investments sold out of Armata Pharmaceuticals (ARMP) in Q4 2021, closing a stake of 21 shares.

Harbour Investments first reported a position in ARMP in Q1 2021 and held it in 3 quarters. The position peaked at $0 in Q3 2021. 17 funds tracked by Wall St. Rank hold ARMP as of Q4 2021.

  • Harbour Investments reported no remaining Armata Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 21 Armata Pharmaceuticals shares in Q4 2021.
  • Harbour Investments first reported a position in Armata Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's Armata Pharmaceuticals position peaked at $0 in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.